Regeneron Pharmaceuticals

Regeneron Pharmaceuticals is a leading American biotechnology company that invents, develops, and commercializes life-transforming medicines for serious diseases, including eye conditions, cancer, and inflammatory disorders. Founded in 1988 and headquartered in New York, the firm utilizes proprietary technologies like VelociSuite to accelerate drug discovery and maintain a robust clinical pipeline. The company is known for major products such as Eylea and Dupixent, and it recently launched Otarmeni, the first FDA-approved gene therapy for a specific form of genetic hearing loss.

Cómo comprar Regeneron Pharmaceuticals en Grow →